Insider Transactions

Insider Transactions

Date Filer Title Filing Type Shares Traded Price Total Held
Feb 11, 2026
CHIEF LEGAL OFFICER
CHIEF LEGAL OFFICER Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 $29.70 22,835
Feb 11, 2026
CHIEF LEGAL OFFICER
CHIEF LEGAL OFFICER Form 4 Open market or private sale of non-derivative or derivative security 10,000 $54.00 12,835
Feb 11, 2026
CHIEF LEGAL OFFICER
CHIEF LEGAL OFFICER Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,000 -- 35,000
Jan 15, 2026
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 11,000 $26.11 20,930
Jan 15, 2026
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 9,290 $48.12 11,640
Jan 15, 2026
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 1,710 $48.85 9,930
Jan 15, 2026
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 11,000 -- --
Jan 08, 2026
Director, President, CEO
Director, President, CEO Form 4 Open market or private sale of non-derivative or derivative security 14,281 $44.71 479,344
Jan 08, 2026
Chief Medical Officer
Chief Medical Officer Form 4 Open market or private sale of non-derivative or derivative security 3,650 $44.71 42,088
Jan 08, 2026
CHIEF LEGAL OFFICER
CHIEF LEGAL OFFICER Form 4 Open market or private sale of non-derivative or derivative security 2,210 $44.71 12,835

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.